These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 19452574)
1. Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk. Shadman M; Newcomb PA; Hampton JM; Wernli KJ; Trentham-Dietz A World J Gastroenterol; 2009 May; 15(19):2336-9. PubMed ID: 19452574 [TBL] [Abstract][Full Text] [Related]
2. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use. Samadder NJ; Mukherjee B; Huang SC; Ahn J; Rennert HS; Greenson JK; Rennert G; Gruber SB Cancer; 2011 Apr; 117(8):1640-8. PubMed ID: 21472711 [TBL] [Abstract][Full Text] [Related]
3. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study. Vinogradova Y; Hippisley-Cox J; Coupland C; Logan RF Gastroenterology; 2007 Aug; 133(2):393-402. PubMed ID: 17681160 [TBL] [Abstract][Full Text] [Related]
4. Statin use and risk of colorectal cancer. Coogan PF; Smith J; Rosenberg L J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111 [TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316 [TBL] [Abstract][Full Text] [Related]
6. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Flick ED; Habel LA; Chan KA; Haque R; Quinn VP; Van Den Eeden SK; Sternfeld B; Orav EJ; Seeger JD; Quesenberry CP; Caan BJ Drugs; 2009 Jul; 69(11):1445-57. PubMed ID: 19634923 [TBL] [Abstract][Full Text] [Related]
7. Statin and NSAID use and prostate cancer risk. Coogan PF; Kelly JP; Strom BL; Rosenberg L Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):752-5. PubMed ID: 20582910 [TBL] [Abstract][Full Text] [Related]
8. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study. Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788 [No Abstract] [Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study. Kho PF; Fawcett J; Fritschi L; Risch H; Webb PM; Whiteman DC; Neale RE Cancer Causes Control; 2016 Dec; 27(12):1457-1464. PubMed ID: 27817122 [TBL] [Abstract][Full Text] [Related]
10. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study. Baandrup L Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052 [TBL] [Abstract][Full Text] [Related]
11. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study. Hoffmeister M; Chang-Claude J; Brenner H Int J Cancer; 2007 Sep; 121(6):1325-30. PubMed ID: 17487832 [TBL] [Abstract][Full Text] [Related]
12. Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study. Mamtani R; Lewis JD; Scott FI; Ahmad T; Goldberg DS; Datta J; Yang YX; Boursi B PLoS Med; 2016 Apr; 13(4):e1002007. PubMed ID: 27116322 [TBL] [Abstract][Full Text] [Related]
13. Statin use and the risk of colorectal cancer: a population-based case-control study. Cheng MH; Chiu HF; Ho SC; Tsai SS; Wu TN; Yang CY World J Gastroenterol; 2011 Dec; 17(47):5197-202. PubMed ID: 22215945 [TBL] [Abstract][Full Text] [Related]
14. Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom. Burr NE; Talboys RJ; Savva S; Clark A; Phillips M; Metcalfe M; Dennison A; Robinson R; Lewis MP; Rhodes M; Rushbrook S; Hart AR Dig Dis Sci; 2014 Jul; 59(7):1567-72. PubMed ID: 24535250 [TBL] [Abstract][Full Text] [Related]
15. Statins and the risk of colorectal cancer. Poynter JN; Gruber SB; Higgins PD; Almog R; Bonner JD; Rennert HS; Low M; Greenson JK; Rennert G N Engl J Med; 2005 May; 352(21):2184-92. PubMed ID: 15917383 [TBL] [Abstract][Full Text] [Related]
16. The causes and effects of socio-demographic exclusions from clinical trials. Bartlett C; Doyal L; Ebrahim S; Davey P; Bachmann M; Egger M; Dieppe P Health Technol Assess; 2005 Oct; 9(38):iii-iv, ix-x, 1-152. PubMed ID: 16181564 [TBL] [Abstract][Full Text] [Related]
17. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study. Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286 [TBL] [Abstract][Full Text] [Related]
18. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study. Beales IL; Vardi I; Dearman L; Broughton T Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236 [TBL] [Abstract][Full Text] [Related]
19. Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention. Xiao H; Yang CS Int J Cancer; 2008 Sep; 123(5):983-90. PubMed ID: 18548583 [TBL] [Abstract][Full Text] [Related]
20. For patients with colorectal cancer, the long-term use of statins is associated with better clinical outcomes. Siddiqui AA; Nazario H; Mahgoub A; Patel M; Cipher D; Spechler SJ Dig Dis Sci; 2009 Jun; 54(6):1307-11. PubMed ID: 19337834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]